A man from Florida has confessed to his involvement in a fraud scheme related to healthcare during the COVID-19 pandemic, as reported by the U.S. Attorney’s Office for the Eastern District of Michigan on Thursday.
Hasan “Lucas” Seyhun, 45, originally from Miami, entered a guilty plea on Wednesday for conspiring to commit healthcare fraud. He was implicated in submitting over $500 million in fraudulent claims to government-supported health programs, according to a news release from the Department of Justice (DOJ).
Previously, Seyhun was the chief operating officer at Fast Lab Technologies, a New York-based company that offered “no-cost” COVID-19 tests that customers could buy online. Fast Lab allegedly used customers’ insurance details to fraudulently charge for services that were never provided—like claims that medical professionals oversaw antigen tests or that medical staff collected saliva samples, as outlined by the DOJ.
“While Americans were understandably worried about their lives and families, Hasan Seyhun chose to take advantage of the crisis for his financial gain,” Assistant Attorney General Colin M. McDonald from the National Fraud Enforcement Division stated. “Instead of offering the necessary support during this critical period, Seyhun and his associates betrayed the trust of the American people, profiting from fraudulent insurance claims.”
McDonald emphasized that the Fraud Division is dedicated to pursuing those who exploited the pandemic for personal gain.
$500 MILLION in fake COVID-19 test billing fraud has been uncovered and Hasan Seyhun, the Chief Operating Officer, will be held accountable for ripping off the American people.
“At a time when Americans were scared for their families and their futures, Hasan Seyhun saw an…
— National Fraud Enforcement Division (@DOJFraudDiv) September 24, 2026
U.S. Attorney Jerome F. Gorgon Jr. noted that Seyhun and his co-conspirators were so confident that they often filed claims for payment even before the test kits were sent out to customers.
This announcement arrives as the Trump administration continues to address healthcare fraud across the nation, with reports revealing that more than $1.2 billion in suspected fraud has been identified across five contracts related to COVID-19.
